Full Press Release Details
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference.
IRON
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference
Key Takeaway: Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference
Price reaction · baseline $46.61 (2025-05-12 close) · hit after-hours · 1 other IRON headline(s) in the window, move may be shared
day 0 close · peak
-0.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)